Cargando…

Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma

PURPOSE: Early prediction of treatment outcomes represents an essential step towards increased treatment efficacy and survival in patients with hepatocellular carcinoma (HCC). In this study, we performed two-dimensional electrophoresis (2-DE) followed by protein profiling to identify biomarkers pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eun-Jung, Yang, Seung-Hyun, Kim, Kyoung-Jin, Cha, Hyejung, Lee, Seo Jin, Kim, Ji-Hye, Song, Junkyu, Chun, Kyung-Hee, Seong, Jinsil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056950/ https://www.ncbi.nlm.nih.gov/pubmed/28724284 http://dx.doi.org/10.4143/crt.2016.550

Ejemplares similares

Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model
por: Kim, Kyoung-Jin, et al.
Publicado: (2017)

Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
por: Cha, Hyejung, et al.
Publicado: (2017)

Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
por: Choi, Yunseon, et al.
Publicado: (2014)

Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells
por: Lee, Eun-Jung, et al.
Publicado: (2016)

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
por: Cha, Hyejung, et al.
Publicado: (2013)

Strategic application of radiotherapy for hepatocellular carcinoma
por: Choi, Seo Hee, et al.
Publicado: (2018)

High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
por: Kim, Taehyung, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
por: Choi, Seo Hee, et al.
Publicado: (2018)

Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
por: Byun, Hwa Kyung, et al.
Publicado: (2023)

Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)

Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)
por: Cha, Hyejung, et al.
Publicado: (2017)

Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma
por: Jeong, Keun-Yeong, et al.
Publicado: (2015)

Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2022)

Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma
por: Lee, Byung min, et al.
Publicado: (2023)

The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2012)

Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

Urine inter‐alpha‐trypsin inhibitor family‐related proteins may serve as biomarkers for disease activity of lupus
por: Jiang, Jun, et al.
Publicado: (2022)

Inter-floor noise classification using convolutional neural network
por: Shin, Hye-kyung, et al.
Publicado: (2020)

Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
por: Lee, Byung Min, et al.
Publicado: (2021)

Initial Tumor Necrosis Factor-Alpha and Endothelial Activation Are Associated with Hemorrhagic Complications during Extracorporeal Membrane Oxygenation
por: Jang, Jin Ho, et al.
Publicado: (2023)

Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2014)

Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
por: Seong, Jinsil
Publicado: (2009)

Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
por: Kim, Nalee, et al.
Publicado: (2022)

Initial treatment response and short-term mortality of spontaneous bacterial peritonitis in cirrhotic patients with hepatocellular carcinoma
por: Lee, Chang Hun, et al.
Publicado: (2023)

Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma
por: Park, Sangjoon, et al.
Publicado: (2018)

Re-Irradiation of Hepatocellular Carcinoma: Clinical Applicability of Deformable Image Registration
por: Lee, Dong Soo, et al.
Publicado: (2016)

Surgical and Electrical Anatomy of the Inter-Nodal and Intra-Atrial Conduction System in the Heart
por: Seo, Jeong-Wook, et al.
Publicado: (2022)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
por: Lee, Byung Min, et al.
Publicado: (2021)

Shelf Life Prediction of Vacuum-Packaged Grilled Mackerel
por: Park, Jae-Hee, et al.
Publicado: (2023)

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
por: Han, Sojung, et al.
Publicado: (2020)

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
por: Cho, In Rae, et al.
Publicado: (2017)

Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
por: Kim, Beom Kyung, et al.
Publicado: (2019)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
por: Yoo, Eun Jin, et al.
Publicado: (2013)

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
por: Kim, Yong Tae, et al.
Publicado: (2023)

Inter- and Intra-observer Reliability of MRI for Lumbar Lateral Disc Herniation
por: Kim, Seong Wan, et al.
Publicado: (2009)

The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
por: Choi, Sae Byeol, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h746v72df2vsvvj3j0bbh7c242